Every ATMP program carries the same underlying risk: decisions made on incomplete or delayed cellular data ripple forward into failed runs, tech transfer delays, and costly regulatory rework. Radiance® exists to close that gap. It is LumaCyte’s next-generation single-cell analysis instrument, built to give scientists real-time, quantitative insight into individual cell vitality, predictive function, and functional potency, the exact attributes that determine whether a manufacturing run succeeds or fails long before that outcome is visible in downstream assays.
As a cellular Process Analytical Technology (PAT) platform, Radiance® gives development and production scientists something most cell characterization tools cannot: label-free, single-cell measurements of Critical Material Attributes and CPP-sensitive in-process CQA surrogates, delivered in minutes rather than days. That speed matters because it changes when a decision can be made. Instead of learning after the fact that cellular starting material was suboptimal or a process parameter drifted, teams can catch and correct these issues in real time, protecting yield, schedule, and budget. The platform’s multiattribute data also feeds directly into predictive machine-learning models, so the value compounds: each run makes the next one more predictable.
